loadpatents
Patent applications and USPTO patent grants for Gastwirt; Randy.The latest application filed is for "fully human antibodies that bind to vascular endothelial growth factor receptor (vegfr2)".
Patent | Date |
---|---|
Fully Human Antibodies That Bind to Vascular Endothelial Growth Factor Receptor (VEGFR2) App 20220025054 - Gastwirt; Randy ;   et al. | 2022-01-27 |
Antigen Binding Proteins that Bind c-Met App 20220002422 - Swanson; Barbara A. ;   et al. | 2022-01-06 |
Antigen Binding Proteins That Bind PD-L1 App 20210330787 - Zhou; Heyue ;   et al. | 2021-10-28 |
Antigen binding proteins that bind c-Met Grant 11,155,628 - Swanson , et al. October 26, 2 | 2021-10-26 |
Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) Grant 11,111,304 - Gastwirt , et al. September 7, 2 | 2021-09-07 |
Antigen binding proteins that bind PD-L1 Grant 11,027,012 - Zhou , et al. June 8, 2 | 2021-06-08 |
Methods for blocking an interaction between notch-1 and delta-like 4 (DLL-4) by administering a DDL-4 antibody Grant 10,717,779 - Gros , et al. | 2020-07-21 |
Antibodies which bind insulin-like growth factor receptor-1 (IGF1R) and methods of use thereof to treat cancer Grant 10,519,245 - Gastwirt , et al. Dec | 2019-12-31 |
Antigen Binding Proteins That Bind C-Met App 20190359719 - Swanson; Barbara A. ;   et al. | 2019-11-28 |
Antigen binding proteins that bind c-met Grant 10,377,827 - Swanson , et al. A | 2019-08-13 |
Antigen Binding Proteins that Bind DLL-4 App 20190169282 - GROS; Edwige ;   et al. | 2019-06-06 |
Antigen Binding Proteins That Bind Pd-l1 App 20190060451 - Zhou; Heyue ;   et al. | 2019-02-28 |
Fully Human Antibodies that Bind to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) App 20190048087 - Gastwirt; Randy ;   et al. | 2019-02-14 |
Antigen binding proteins that bind delta-like 4 (DLL-4) Grant 10,174,107 - Gros , et al. J | 2019-01-08 |
Antigen binding proteins that bind PD-L1 Grant 10,058,609 - Zhou , et al. August 28, 2 | 2018-08-28 |
Antibodies that bind epidermal growth factor receptor (EGFR) Grant 9,944,707 - Zhou , et al. April 17, 2 | 2018-04-17 |
Antigen Binding Proteins That Bind Pd-l1 App 20170281765 - Zhou; Heyue ;   et al. | 2017-10-05 |
Antigen Binding Proteins that Bind c-Met App 20170283501 - Swanson; Barbara A. ;   et al. | 2017-10-05 |
Antigen Binding Proteins that Bind PD-L1 App 20170182161 - Zhou; Heyue ;   et al. | 2017-06-29 |
Fully Human Antibodies that Bind to VEGFR2 App 20170166644 - Gastwirt; Randy ;   et al. | 2017-06-15 |
Antigen binding proteins that bind PD-L1 Grant 9,175,082 - Zhou , et al. November 3, 2 | 2015-11-03 |
Fully human antibodies that bind to VEGFR2 and methods of use thereof Grant 9,029,510 - Gastwirt , et al. May 12, 2 | 2015-05-12 |
Fully Human Antibodies that Bind to VEGFR2 App 20140294827 - Gastwirt; Randy ;   et al. | 2014-10-02 |
Antigen Binding Proteins that Bind IGF1R App 20130344069 - Gastwirt; Randy ;   et al. | 2013-12-26 |
Antigen Binding Proteins that Bind DLL-4 App 20130323248 - Gros; Edwige ;   et al. | 2013-12-05 |
Antigen Binding Proteins that Bind PD-L1 App 20130323249 - Zhou; Heyue ;   et al. | 2013-12-05 |
Antigen Binding Proteins that Bind EGFR App 20130309233 - Zhou; Heyue ;   et al. | 2013-11-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.